Latest News Archive
Please select Category, Year, and then Month to display items
07 March 2025
|
Story Anthony Mthembu
|
Photo Supplied
Crystal-Donna Roberts, recipient of the 2016 Kovsie Ambassador Award and award-winning actress, has died following a battle with breast cancer.
The University of the Free State (UFS) is deeply saddened by the passing of alumna and award-winning actress Crystal-Donna Roberts at the age of 41. According to Eyewitness News (EWN), Roberts passed away during the early hours of 6 March 2025, following a long battle with breast cancer.
The UFS extends its deepest condolences to Roberts’ family, friends, colleagues, and supporters.
Celebrating a beloved actress
Roberts graduated from the UFS with a BA Drama and Theatre Arts degree in 2005 and went on to create work that was beloved across the country and beyond. She starred in the Afrikaans soap opera 7de Laan and shows like Getroud Met Rugby, Montana and Vallei van Sluiers, among others. Her lead role in the film Krotoa earned her the Best Actress award in 2018 at the South African Film and Television Awards (SAFTAs).
Her extensive career in film and television was one of the reasons she was recognised by the UFS with the Kovsie Ambassador Award in 2016. This is an award given to alumni whose accomplishments have not only benefited themselves but their community and the UFS. Although Roberts was well-known for her work on stage and screens, she was also an author. She released her debut novel Speurder Sammi: Die blou steen (Detective Sammi: The Blue Stone) in 2022.
Outpouring of praise
Since the news of Roberts’ passing broke, there has been an outpouring of tributes on social media. Many of her supporters and colleagues have described her as an iconic force who was full of life and inspired many. Alistair Izobell, who starred alongside Roberts in Arendsvlei, responded to the news through a Facebook post which said, “My dearest sister Crystal-Donna Roberts my heart is broken today. You got your wings and your pain is no more. I am thrilled I got to do a chapter of my life with you. I will remember you with the great spirit you were. Now rest sweetly.”
Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS
Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.
He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.
Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.
The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.
Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.
“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.
“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.